EFDID: 160249EFD: View Filing

Issuer: Ashvattha Therapeutics, LLC (0001668528) - D

Accession: 0000914760-16-000382 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001668528
  • Entity Name:
    Ashvattha Therapeutics, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    CALIFORNIA
  • Year of Inc:
    Within 5 years (2015)
  • Address:
    303 TWIN DOLPHIN DRIVE, SUITE 600
    REDWOOD CITY, CA 94065
  • Persons:
    Related Persons 4
    Jeffrey Cleland
    Executive Officer 
    Manager of Company
    Sujatha Kannan
    Executive Officer 
    Manager of Company
    Kannan Rangaramanujam
    Executive Officer 
    Manager of Company
    Justin Hanes
    Executive Officer 
    Manager of Company
EDGAR: Offering Information
  • Accession Date:
    03/03/2016
  • First Sale Date:
    02/24/2016
  • Offering Amount:
    $700,000
  • Amount Sold:
    $300,000
  • Amount Remaining:
    $400,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA
Inactive:MD, NV
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ashvattha Therapeutics, LLC/s/ Jeffrey ClelandJeffrey ClelandPresident2016-03-03